Back to results
US 9,808,504 B2Granted
Immunogenic epitopes as targets for universal cancer vaccines
AssigneeYale University
InventorsKavita Dhodapkar, Madhav Dhodapkar
Life of this patent
Estimating the term…
Abstract
The present invention provides a peptide having an amino acid sequence as set forth in SEQ ID NOs: 1 through 95 and any combination thereof. The peptide or combination of peptides possess OCT4 specific inducibility. The peptide or combination of peptides can further be used as a vaccine.
Claims4
A composition comprising a plurality of OCT4 peptides, each said OCT4 peptide consisting of a peptide selected from the group consisting of SEQ ID NO:
- 53 and SEQ ID NO:
- 74, and further comprising an adjuvant, and one or more pharmaceutically acceptable excipients.
A composition comprising a plurality of isolated OCT4 peptides, each said OCT4 peptide consisting of a peptide selected from the group consisting of SEQ ID NO:
- 53 and SEQ ID NO:
- 74, and further comprising an adjuvant, and one or more pharmaceutically acceptable excipients.
Dependencies are inferred from the claim text.